Khiron Pharma Commerce ApS: Financial statements 2023
CVR: 37003204
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Khiron Pharma Commerce ApS (CVR 37003204) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 154,052 and a net result of DKK 133,810 compared with DKK -62,129 the year before. Equity in the 2023 report amounted to DKK 171,334. The solvency ratio was 30.4%.
- Gross Profit
- DKK 154,052
- Profit/Loss
- DKK 133,810
- Equity
- DKK 171,334
- Total Assets
- DKK 563,137
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 154 t. | 134 t. | 171 t. | 0 |
| 2022 | - | -61 t. | -62 t. | 38 t. | 0 |
| 2021 | - | 130 t. | 55 t. | 100 t. | 1 |
| 2020 | - | -33 t. | -69 t. | 45 t. | 1 |
| 2019 | - | 218 t. | 64 t. | 114 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Khiron Pharma Commerce ApS has published its annual report for 2022. Gross profit came to DKK -60,982, and the net result was DKK -62,129.
About Khiron Pharma Commerce ApS
Khiron Pharma Commerce ApS is a Danish company of the type Anpartsselskab based in Frederiksværk, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dan Henning Norden and Lone Lindquist-Nielsen. The company's owners include Lone Lindquist-Nielsen, Dan Henning Norden and Mette Rokkedal. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 780,426 and a net result of DKK 339,637 compared with DKK 4,240 the year before. Equity in the 2025 report amounted to DKK 515,211.